Synopsys Other Income (Expense) decreased by 23.2% to $38.72M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 23.2%, from $50.42M to $38.72M. Over 2 years (FY 2021 to FY 2024), Other Income (Expense) shows an upward trend with a 66.0% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $21.76M | $11.41M | $8.79M | -$19.79M | -$23.91M | $2.43M | -$3.98M | $23.29M | $4.21M | $25.48M | $104.83M | $9.46M | $31.78M | $48.91M | $50.42M | $38.72M |
| QoQ Change | — | -47.6% | -23.0% | -325.2% | -20.8% | +110.1% | -264.1% | +684.9% | -81.9% | +505.0% | +311.3% | -91.0% | +236.1% | +53.9% | +3.1% | -23.2% |
| YoY Change | — | — | — | — | -209.9% | -78.7% | -145.3% | +217.7% | +117.6% | +950.5% | +350.1% | +124.5% | +24.7% | — | -51.9% | -23.2% |